ArticleFrontiers in artificial intelligence2023
Explainability as the key ingredient for AI adoption in Industry 5.0 settings.
Article in Frontiers in artificial intelligence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Explainable Artificial Intelligence (XAI) has gained significant attention as a means to address the transparency and interpretability challenges posed by black box AI models. In the context of the manufacturing industry, where complex problems and decision-making processes are widespread, the XMANAI platform emerges as a solution to enable transparent and trustworthy collaboration between humans and machines. By leveraging advancements in XAI and catering the prompt collaboration between data scientists and domain experts, the platform enables the construction of interpretable AI models that offer high transparency without compromising performance. This paper introduces the approach to building the XMANAI platform and highlights its potential to resolve the "transparency paradox" of AI. The platform not only addresses technical challenges related to transparency but also caters to the specific needs of the manufacturing industry, including lifecycle management, security, and trusted sharing of AI assets. The paper provides an overview of the XMANAI platform main functionalities, addressing the challenges faced during the development and presenting the evaluation framework to measure the performance of the delivered XAI solutions. It also demonstrates the benefits of the XMANAI approach in achieving transparency in manufacturing decision-making, fostering trust and collaboration between humans and machines, improving operational efficiency, and optimizing business value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.